Skip to main content

LINCOLN NATIONAL CORP

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

LNC$42.98+7.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(in millions, except share data)

As of December 31,
20232022
ASSETS
Investments:
Fixed maturity available-for-sale securities, at fair value
(amortized cost: 2023 - $97,433; 2022 - $111,707; allowance for credit losses: 2023 - $19; 2022 - $22)$88,738$99,736
Trading securities2,3593,498
Equity securities306427
Mortgage loans on real estate, net of allowance for credit losses
(portion at fair value: 2023 - $288; 2022 - $487)18,96318,301
Policy loans2,4762,359
Derivative investments6,4743,594
Other investments5,0153,739
Total investments124,331131,654
Cash and invested cash3,3653,343
Deferred acquisition costs, value of business acquired and deferred sales inducements12,39712,235
Reinsurance recoverables, net of allowance for credit losses29,84319,953
Deposit assets, net of allowance for credit losses28,78911,628
Market risk benefit assets3,8942,807
Accrued investment income1,0821,253
Goodwill1,1441,144
Other assets9,3116,778
Separate account assets158,257143,536
Total assets$372,413$334,331
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Policyholder account balances$120,737$114,435
Future contract benefits39,86438,826
Funds withheld reinsurance liabilities17,6415,740
Market risk benefit liabilities1,7162,078
Deferred front-end loads5,9015,091
Payables for collateral on investments8,1056,712
Short-term debt250500
Long-term debt5,6995,955
Other liabilities7,3506,356
Separate account liabilities158,257143,536
Total liabilities365,520329,229
Contingencies and Commitments (See Note 18)
Stockholders’ Equity
Preferred stock – 10,000,000 shares authorized:
Series C preferred stock – 20,000 shares authorized, issued and outstanding as of December 31, 2023493493
Series D preferred stock – 20,000 shares authorized, issued and outstanding as of December 31, 2023493493
Common stock – 800,000,000 shares authorized; 169,666,137 and 169,220,511 shares
issued and outstanding as of December 31, 2023, and December 31, 2022, respectively4,6054,544
Retained earnings4,7785,924
Accumulated other comprehensive income (loss)(3,476)(6,352)
Total stockholders’ equity6,8935,102
Total liabilities and stockholders’ equity$372,413$334,331

See accompanying Notes to Consolidated Financial Statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.